A novel antifungal antibiotic, TAN-950 complex, was isolated from the culture filtrate of Streptomycesplatensis A-1 36 (IFO 14603, FERMBP-1786). The water-soluble amphoteric substances in this complex were purified by chromatography using ion-exchange resins, QAE-Sephadexand adsorptive resins and were designated TAN-950A and TAN-950A~Emixture. The molecular formula of TAN-950A was determined to be C6H7N2O4Na for the sodium salt. This newamino acid antibiotic showed antifungal activity against Candida albicans in vitro and in vivo, and had low toxicity in mice.
A novel antifungal antibiotic, TAN-950 complex, was isolated from the culture filtrate of Streptomycesplatensis A-1 36 (IFO 14603, FERMBP-1786). The water-soluble amphoteric substances in this complex were purified by chromatography using ion-exchange resins, QAE-Sephadexand adsorptive resins and were designated TAN-950A and TAN-950A~Emixture. The molecular formula of TAN-950A was determined to be C6H7N2O4Na for the sodium salt. This newamino acid antibiotic showed antifungal activity against Candida albicans in vitro and in vivo, and had low toxicity in mice.
In the course of screening for new antifungal antibiotics, a strain of Syreptomyces platensis was selected for isolation of its antifungal metabolite. From the broth nitrate, a fat-soluble component having wide antifungal activity was firstly isolated and identified as a known antifungal antibiotic, trichostatin A1}. The aqueous layer after extraction with ethyl acetate (EtOAc) also showed antifungal activity especially against Candida albicans in the diffusion assay. Thus, an amphoteric substance, TAN-950 A, was isolated as a new amino acid antibiotic. The chemical structure of TAN-950A was determined to be (S)-2-amino-3-(2,5-dihydro-5-oxo-4-isoxazolyl)propanoic acid as is shown in Fig. 1 2) . This paper deals with the taxonomy of the producing organism and the production and antifungal activities of TAN-950 A.
Materials and Methods Taxonomic Studies on the Antibiotic-producing Strain
Methods adopted by the International Streptomyces Project (ISP) were used for taxonomic characterization and carbohydrate utilization studies. The color notations are those of the Color Harmony Manual, 4th Ed.3). Observations were made after incubation at 28°C for 21 days. The procedure of Lechevalier was used to prepare the cells and chromatographically detect the isomers of diaminopimelic acid.
In Vitro Antifungal Acivity The antifungal activity of TAN-950 A was determined on yeast nitrogen base (Difco) supplemented with 2% glucose and 1.5% agar. A conventional agar dilution method was used. The MICfor filamentous fungi and yeasts was expressed in terms of^g/ml after incubation for 48~72 hours at 28°C.
Amino Acid Antagonism Antagonismof amino acids was determined on yeast nitrogen base (Difco) supplemented with 2% glucose and 1.5% agar. A testing amino acid was included in an assay medium. A conventional agar diffusion method was used. Protective Effect in Mice Five-week old female CF#1mice were given an intravenous injection of 1 x 106cfu of C. albicans TA, and antibiotics were administered orally or subcutaneously 0 and 2 hours later. ED50(total dose giving 50%survival) values were calculated from the survival rate 7 days after infection.
Results

Taxonomy of the Producing Strain
The producing organism, strain A-136, was isolated from a soil sample collected in West Germany. The vegatative mycelia were well developed. Aerial mycelia were branched and formed spiral chains of spores. Carbon source utilization by strain A-136 was examined on ISP medium 9. The pattern of carbon utilization by strain A-136 is shown in Table 2 .
nose, and L-arabinose were utilized, but rhamnose and sucrose were not. LL-Diaminopimelic acid was detected in whole cell hydrolysates of the culture. and pH (å¡).
Based on the taxonomic properties described above, strain A-1 36 was considered to belong to the genus Streptomyces. Therefore, the characteristics of the strain were comparedwith published descriptions of various Streptomyces*^. Consequently, strain A-136 was designated Streptomyces platensis A-136.
Fermentation
A slant culture of strain A-136 was inoculated into a 2-liter flask containing 500 ml of the seed culture medium consisting of 2% glucose, 3% soluble starch, 1% soybean flour, 1% corn steep liquor, 0.5% Polypeptone (Daigo Nutritive Chem., Ltd.), 0.3% NaCl and 0.5% CaCO3 and adjusted to pH 7.0 before sterilization. The flask was incubated on a reciprocal shaker at 28°C for 48 hours. Five hundred ml of the seed culture were transferred to a 50-liter fermenter containing 30 liters of the seed culture medium supplemented with 0.05% Actocol (Takeda Chem. Inc.). The seed culture was carried out at 28°C for 48 hours under aeration of 30 liters/minute and agitation of 280 rpm.
Six liters of the seed culture were transferred to a 200-liter fermenter containing 120 liters of the fermentation medium consisting of 0.5% glucose, 5% dextrin, 3.5% soybean meal, 0.7% CaCO3, and 0.05% Actocol and adjusted to pH 7.0 before sterilization.
The fermentation was carried out at 28°C for 90 hours under aeration of 120 liters/minute and agitation of 200 rpm. Glucose was determined by the glucose oxidase system. The growth was determined by packed cell volume. The progress of fermentation was monitored by checking the size of the inhibition zone using Candida albicans.
The time course of antibiotic production in a 200-liter fermenter is shown in Fig. 3 . Antibiotic production reached about 750^g/ml at 120 hours after inoculation. broth (100 liters) was adjusted to pH 8 and filtered using a Hyflo Super Cel. The filtrate (85 liters) adjusted to pH 3 was washed with EtOAc. The concentrate of the aqueous layer was applied at pH 5 to a column of Amberlite IR-120. An antibiotic was eluted with 2%aqueous ammonia, and the eluate was concentrated. The concentrate was passed through a column of Diaion HP-20 washed with water. The concentrate of the effluent was chromatographed on a column of Diaion SP-207 eluting with water. The bioactive fractions were chromatographed on a column of QAE-Sephadex A-25 eluting with 0.02~0.04m NaCl. The pure fractions detected by HPLCwere combined, concentrated and chromatographed on microcrystalline cellulose eluting with acetonitrile-water (9: 1 to 4: 1) to afford a white powder of TAN-950A as the monosodium salt (2.59 g). Upon QAE-Sephadex A-25 chromatography, fractions containing mainly TAN-950 B, C, D and E were combined and applied to a column ofAmberlite IR-120 (H+ type, 0.8 liter) eluting with 2% aqueous ammonia. The eluate wasconcentrated and lyophilized to give a white powderof a mixture of TAN-950 A~E(4.1g). We tried to separate TAN-950 B, C, D and E by preparative HPLC, but could not because isomerization proceeded rapidly. Table 3 shows the stability of TAN-950A in phosphate buffer of various pHs. TAN-950A reached an equilibrium state after about one hour. The chemical conversion is described in the previous paper2).
Chemical Characterization of TAN-950 A TAN-950A was isolated as the sodium salt. It is soluble in water, dimethyl sulfoxide and methonal, and sparingly soluble in acetone, ethyl acetate and indicated a maximumat 253nm, suggesting the^^^67
presence of an a,/?-unsaturated carbonyl group. The molecular formula of TAN-950A was determined to be C6H7N2O4Na on the basis of elemental analysis, secondary ion mass spectrum (SI-MS) and 13C NMRdata. The structure determination of TAN-950 A is described in another paper2).
Biological
Activity MICs for TAN-950 A against 10 different molds and yeasts are shown in Table 5 . TAN-950 A showed strong activity against several yeasts with MICvalues of 0.78~3.13 /ig/ml. However, growths of molds tested were not inhibited at the concentration of 100 /ig/ml.
It was found also that the activity against yeasts was not observed in Sabouraud dextrose agar. The effect of amino acids on the activity of TAN-950A was examined. Of the amino acids tested, glutamic acid, aspartic acid and leucine greatly reduced the antifungal activity of TAN-950A as shown in Table 6 .
In vivo antifungal activity of subcutaneously (sc) and orally (po) administrated TAN-950 A was examined in mice with a systemic Candida albicans TAinfection. The activity of miconazole was used for comparison, and the date are shown in Table 7 . TAN-950A showed 50% effective doses against systemic candidiasis at 35.5 mg/kg (sc) and 100 mg/kg (po). The efficacy was slightly weaker than that ofmiconazole.
TAN-950 A did not cause any toxic changes in mice during a 2-week observation period following Glutamic acid, aspartic acid and leucine greatly reduced the antifungal activity of TAN-950A against Saccharomyces cerevisiae. TAN-950A had no effect on the activity of transaminase from C. albicans or glutamate dehydrogenase from S. cerevisiae. As leucine is an essential amino acid for mammals,some relationship may exist between biological activity of TAN-950 A and the antagonism by amino acids. Two amino acid antibiotics have recently been reported. One is (*S)-2-amino-5-hydroxy-4-oxo pentanoic acid (HON6)or RI-3317)), which was active against yeasts in vitro and in vivo. Wefound that this compound was antagonized by methionine (data not shown). The other is (-)-(li?,25)-2-amino-cyclopentane-lcarboxylic acid (ACPC)8'9), which had already been isolated as a new cyclic /?-amino acid10) which is a part of aminoacyl nucleoside antibiotic, amipurimycin1 X). ACPCwas antagonized by valine and isoleucine (data not shown). It may be that these types of antibiotics will become useful drugs for systemic fungal infections because of their selective toxicity. Antagonism of TAN-950A by glutamic acid and aspartic acid and its glutamate-analogous structure led to the idea that this compound shows affinity for excitatory amino acid receptors (kainate, quisqulate and 7V-methyl-D-aspartate subtypes) in the central nervous system. It was found to bind strongly to these receptors and also to elicit the firing of rat hippocampal CA1neurons in vitro12'13\
